Browsing by Author Van Gaal, Luc

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)Citation
2013Association of hypoglycemic treatment regimens with cardiovascular outcomes in overweight and obese subjects with type 2 diabetes: A substudy of the SCOUT trialCaterson, Ian; Andersson, Charlotte; Coutinho, Walmir; Finer, Nick; Ghotbi, Adam; James, W; Køber, Lars; Sharma, Arya; Torp-Pedersen, Christian; Van Gaal, Luc; Boden InstituteAssociation of hypoglycemic treatment regimens with cardiovascular outcomes in overweight and obese subjects with type 2 diabetes: A substudy of the SCOUT trial, Diabetes Care, vol.36, 11, 2013,pp 3746-3753
2015Changes in body weight and pulse: outcome events in overweight and obese subjects with cardiovascular disease in the SCOUT trialCaterson, Ian; Espinoza, David; Gebski, Val; Seimon, Radhika; Sweeting, Arianne Natasha; Coutinho, Walmir; Finer, Nick; James, W; Legler, U F; Maggioni, Aldo; Sharma, Arya; Torp-Pedersen, Christian; Van Gaal, Luc; Boden Institute; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Boden Institute; Boden InstituteChanges in body weight and pulse: outcome events in overweight and obese subjects with cardiovascular disease in the SCOUT trial, International Journal of Obesity, vol.39, 5, 2015,pp 849-857
2010Early Response to Sibutramine in Patients Not Meeting Current Label Criteria: Preliminary Analysis of SCOUT Lead-in PeriodCaterson, Ian; Coutinho, Walmir; Finer, Nick; Ge, Hong; James, Philip; Maggioni, Aldo; Santoro, Donatella; Sharma, Arya; Shepherd, Gillian; Torp-Pedersen, Christian; Van Gaal, Luc; Boden InstituteEarly Response to Sibutramine in Patients Not Meeting Current Label Criteria: Preliminary Analysis of SCOUT Lead-in Period, Obesity, vol.18, 5, 2010,pp 987-994
2010Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese SubjectsCaterson, Ian; Coutinho, Walmir; Finer, Nick; James, W; Maggioni, Aldo Pietro; Renz, Cheryl; Rode, Richard; Sharma, Arya; Shepherd, Gillian; Torp-Pedersen, Christian; Van Gaal, Luc; School of Molecular BioscienceEffect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects, New England Journal of Medicine, vol.363, 10,pp 905-917
2010Impact of Waist Circumference Difference on Health-Care Cost among Overweight and Obese Subjects: The PROCEED CohortCaterson, Ian; Aronne, L J; Coste, Florence; Despres, J P; Finer, Nick; Hauner, H; Hill, J O; Pendergast, K B; Sherrill, B H; Van Gaal, Luc; Wolf, A M; Zhou, Xiaolei; School of Molecular BioscienceImpact of Waist Circumference Difference on Health-Care Cost among Overweight and Obese Subjects: The PROCEED Cohort, Value in Health, vol.13, 4,pp 402-410
2012Maintained Intentional Weight Loss Reduces Cardiovascular Outcomes: Results from the Sibutramine Cardiovascular OUTcomes (SCOUT) TrialCaterson, Ian; Coutinho, Walmir; et al, various; Finer, Nick; Legler, U; Maggioni, Aldo; Rode, Richard; Sharma, Arya; Shepherd, Gillian; Torp-Pedersen, Christian; Van Gaal, Luc; Molecular BioscienceMaintained Intentional Weight Loss Reduces Cardiovascular Outcomes: Results from the Sibutramine Cardiovascular OUTcomes (SCOUT) Trial, Diabetes, Obesity and Metabolism, vol.14, 6, 2012,pp 523-530
2017Relation between weight loss and causes of death in patients with cardiovascular disease: Finding from the SCOUT trialCaterson, Ian; Seimon, Radhika; Sweeting, Arianne Natasha; Coutinho, Walmir; Finer, Nick; James, W; Legler, U; Maggioni, Aldo; Sharma, Arya; Torp-Pedersen, Christian; Urso, Renato; Van Gaal, Luc; Boden Institute; Boden Institute; Boden InstituteRelation between weight loss and causes of death in patients with cardiovascular disease: Finding from the SCOUT trial, Journal of Cardiovascular Medicine (Hagerstown), vol.18, 3, 2017,pp 144-151
2008Tolerability of Sibutramine During a 6-week Treatment Period in High-Risk Patients With Cardiovascular Disease and/or Diabetes: A Preliminary Analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) TrialCaterson, Ian; Bacher, Peter; Coutinho, Walmir; Finer, Nick; James, Philip; Maggioni, Aldo; Sharma, Arya; Shepherd, Gillian; Sun, Rui; Torp-Pedersen, Christian; Van Gaal, Luc; Boden InstituteTolerability of Sibutramine During a 6-week Treatment Period in High-Risk Patients With Cardiovascular Disease and/or Diabetes: A Preliminary Analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial, Journal of Cardiovascular Pharmacology, vol.52, 5, 2008,pp 393-402
2013Uric Acid as a Risk Factor for Cardiovascular Disease and Mortality in Overweight/Obese IndividualsCaterson, Ian; Andersson, Charlotte; Coutinho, Walmir; Finer, Nick; James, W; Maggioni, Aldo Pietro; Sharma, Arya; Skak-Nielsen, Helle; Torp-Pedersen, Christian; Van Gaal, Luc; Boden InstituteUric Acid as a Risk Factor for Cardiovascular Disease and Mortality in Overweight/Obese Individuals, PLoS One, vol.8, 3, 2013,pp 1-9